No Data
This week, Hong Kong stocks' star stocks | Expectations of top brokerages merging are hyped! A-share trading is hot! China-affiliated brokerage stocks collectively soaring; shanghai electric group skyrocketed by 62% in one week, officially announcing merg
This week, the Hong Kong stock market ended four consecutive weeks of decline, with daily levels still fluctuating. The Hang Seng Index rose by 1.08% to 20,728.19 points; during the same period, the Hang Seng Tech Index rose by 4.11% to 4,668.26 points; the Hang Seng China Enterprises Index rose by 1.62% to 7,461.44 points.
Hong Kong stock market retreats from its high levels, with the Hang Seng Index and the H-share Index both falling by over 1%; the real estate and brokerage sectors decline, Sunac drops more than 9%, Citic Securities falls by nearly 6%.
Network technology stocks decline, NetEase-S drops by 5.61%, Meituan-W drops by 4.05%; Securities and brokerage stocks weaken, CSC drops by 5.45%, China International Capital Corporation drops by 4.34%; Coal industrial concept stocks weaken, China Coal Energy drops by 4.22%, Kinetic Dev drops by 3.18%.
Genscript Bio (01548): Legend Biotech announces the latest data on the minimal residual disease (MRD) negativity rate related to the phase 3 CARTITUDE-4 trial.
Genscript Bio (01548) announced in a statement that on November 5, 2024, legend biotech will showcase...
Insiders At Genscript Biotech Sold US$12m In Stock, Alluding To Potential Weakness
The first batch of pharmaceutical fund's third quarter report is released! Shareholding in US stocks reduced, while increasing holdings in Hong Kong stocks and A-shares.
The first batch of fund managers exposed in the third quarter medical investment strategy, significantly increased the proportion of innovative drugs, especially the position of Hong Kong-listed innovative drugs with greater flexibility.
Abnormal movement hits the CRO concept in the morning, driven by innovative drug policies and expectations of Fed rate cuts, Pharmaron and Tigermed both rose more than 7%.
CRO concept rose in the morning, as of the time of publication, Frontage Holdings increased by 8.45%, Pharmaron increased by 7.64%, Tigermed increased by 7.99%, and Joinn Laboratories increased by 5.59%.
No Data
No Data